JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Viatris Inc

Fechado

SetorSaúde

10.36 0.58

Visão Geral

Variação de preço das ações

24h

Atual

Mín

10.3

Máximo

10.49

Indicadores-chave

By Trading Economics

Rendimento

3B

-4.6M

Vendas

328M

3.6B

Rendimento de Dividendos

4.72

Margem de lucro

-0.128

Funcionários

32,000

EBITDA

2.9B

578M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+10.47% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

4.72%

2.33%

Próximos Ganhos

6 de nov. de 2025

Próxima data de dividendos

12 de dez. de 2025

Próxima data de ex-dividendo

21 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.5B

12B

Abertura anterior

9.78

Fecho anterior

10.36

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Viatris Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de out. de 2025, 09:10 UTC

Ações em Alta

Stocks to Watch Thursday: HSBC, PepsiCo, MP Materials -- WSJ

Comparação entre Pares

Variação de preço

Viatris Inc Previsão

Preço-alvo

By TipRanks

10.47% parte superior

Previsão para 12 meses

Média 11.5 USD  10.47%

Máximo 15 USD

Mínimo 8 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Viatris Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

4 ratings

1

Comprar

2

Manter

1

Vender

Pontuação Técnica

By Trading Central

8.48 / N/ASuporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Very Strong Bullish Evidence

Longo Prazo

Strong Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat